<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:thr="http://purl.org/syndication/thread/1.0" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
    <title>The Clinical Device Newsletter</title>
    
    
    <link rel="alternate" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/" />
    <id>tag:typepad.com,2003:weblog-86673365395150603</id>
    <updated>2011-01-03T12:10:00-06:00</updated>
    
    <generator uri="http://www.typepad.com/">TypePad</generator>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/atom+xml" href="http://feeds.feedburner.com/TheClinicalDeviceNewsletter" /><feedburner:info uri="theclinicaldevicenewsletter" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://hubbub.api.typepad.com/" /><feedburner:emailServiceId>TheClinicalDeviceNewsletter</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><entry>
        <title>Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans</title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/WKh5O20j5i0/cardium-reports-excellagen-matrix-clinical-study-results-accepted-for-publication-by-peer-reviewed-journal-and-updates-produ.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2011/01/cardium-reports-excellagen-matrix-clinical-study-results-accepted-for-publication-by-peer-reviewed-journal-and-updates-produ.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330148c72cf8f7970c</id>
        <published>2011-01-03T12:10:00-06:00</published>
        <updated>2011-01-03T12:10:00-06:00</updated>
        <summary type="html">Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans PR Newswire SAN DIEGO, Dec. 28, 2010 SAN DIEGO, Dec. 28, 2010 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported that data from the Company's Matrix Phase 2b clinical study has been...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/WKh5O20j5i0" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2011/01/cardium-reports-excellagen-matrix-clinical-study-results-accepted-for-publication-by-peer-reviewed-journal-and-updates-produ.html</feedburner:origLink></entry>
    <entry>
        <title>HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication</title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/lGQuq53VHS0/heartware-files-pma-application-for-fda-approval-of-the-heartware-ventricular-assist-system-for-a-br.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2011/01/heartware-files-pma-application-for-fda-approval-of-the-heartware-ventricular-assist-system-for-a-br.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330148c72cec6b970c</id>
        <published>2011-01-03T12:10:00-06:00</published>
        <updated>2011-01-03T12:10:00-06:00</updated>
        <summary type="html">Dec 28, 2010 07:50 ET HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication PR Newswire FRAMINGHAM, Mass. and SYDNEY, Dec. 28, 2010 FRAMINGHAM, Mass. and SYDNEY, Dec. 28, 2010 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN) today announced that...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/lGQuq53VHS0" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2011/01/heartware-files-pma-application-for-fda-approval-of-the-heartware-ventricular-assist-system-for-a-br.html</feedburner:origLink></entry>
    <entry>
        <title>Vapor Corp. Looks Forward to FDA 'Partnership'</title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/Ub9qExFdMpU/vapor-corp-looks-forward-to-fda-partnership.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2011/01/vapor-corp-looks-forward-to-fda-partnership.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330147e13c62f7970b</id>
        <published>2011-01-03T12:10:00-06:00</published>
        <updated>2011-01-03T12:10:00-06:00</updated>
        <summary type="html">Vapor Corp. Looks Forward to FDA 'Partnership' HALLANDALE, FL--(Marketwire - December 30, 2010) - Vapor Corp. (OTCBB: VPCO), the market leader in the design, marketing and distribution of electronic cigarettes, said today it looks forward to working with FDA as the agency examines regulatory options following a recent federal court...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/Ub9qExFdMpU" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2011/01/vapor-corp-looks-forward-to-fda-partnership.html</feedburner:origLink></entry>
    <entry>
        <title>Say Goodbye to Unwanted Love Handles: CoolSculpting by ZELTIQ(TM) Receives FDA Clearance for Patented, Non-Invasive Cooling Treatment for Fat Reduction </title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/92Yd_jHzwyo/say-goodbye-to-unwanted-love-handles-coolsculpting-by-zeltiqtm-receives-fda-clearance-for-patented-n.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/say-goodbye-to-unwanted-love-handles-coolsculpting-by-zeltiqtm-receives-fda-clearance-for-patented-n.html" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330133f4401036970b</id>
        <published>2010-09-15T07:27:41-05:00</published>
        <updated>2010-10-21T09:37:07-05:00</updated>
        <summary type="html">Revolutionary Procedure Safely Eliminates an Average of 20% Fat in Treated Area - PLEASANTON, Calif., Sept. 8 /PRNewswire/ -- Great news for men and women dealing with one of the most exercise and diet-resistant problem areas: "love handles." CoolSculpting(TM) is now cleared by the U.S. Food and Drug Administration (FDA)...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/92Yd_jHzwyo" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/say-goodbye-to-unwanted-love-handles-coolsculpting-by-zeltiqtm-receives-fda-clearance-for-patented-n.html</feedburner:origLink></entry>
    <entry>
        <title>Three in Ten Americans Would Use Their Cell Phone to Track Personal Health, Finds PricewaterhouseCoopers </title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/-YRzZNc5ZKk/three-in-ten-americans-would-use-their-cell-phone-to-track-personal-health-finds-pricewaterhousecoop.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/three-in-ten-americans-would-use-their-cell-phone-to-track-personal-health-finds-pricewaterhousecoop.html" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330133f4400b6e970b</id>
        <published>2010-09-15T07:24:30-05:00</published>
        <updated>2010-10-21T09:36:54-05:00</updated>
        <summary type="html">40 Percent Would Pay for Remote Monitoring Device to Send Health Information Electronically to Their Doctor SAN DIEGO, Sept. 8 /PRNewswire/ -- Three in ten Americans recently surveyed by PricewaterhouseCoopers' Health Research Institute said they would use their cell or smart phone to track and monitor their personal health, and...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/-YRzZNc5ZKk" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/three-in-ten-americans-would-use-their-cell-phone-to-track-personal-health-finds-pricewaterhousecoop.html</feedburner:origLink></entry>
    <entry>
        <title>  Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study </title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/M7GbSw2NuVo/-luminex-magpix-system-shown-to-be-more-cost-effective-and-efficient-than-conventional-elisa-method-.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/-luminex-magpix-system-shown-to-be-more-cost-effective-and-efficient-than-conventional-elisa-method-.html" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330134875f1d07970c</id>
        <published>2010-09-15T07:18:55-05:00</published>
        <updated>2010-10-21T09:36:21-05:00</updated>
        <summary type="html">AUSTIN, Texas, Sept. 8 /PRNewswire-FirstCall/ -- Luminex Corporation (NASDAQ:LMNX) , today announced that initial results from a study conducted at the NMI Natural and Medical Sciences Institute at the University of Tubingen in Germany demonstrate that its MAGPIX® system provides more cost effective and efficient results than a conventional microtiter...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/M7GbSw2NuVo" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/-luminex-magpix-system-shown-to-be-more-cost-effective-and-efficient-than-conventional-elisa-method-.html</feedburner:origLink></entry>
    <entry>
        <title>Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients </title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/0YvvKD2rhzk/stereotaxis-announces-first-ever-prospective-comparative-clinical-trial-outcome-for-vt-patients-.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/stereotaxis-announces-first-ever-prospective-comparative-clinical-trial-outcome-for-vt-patients-.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330133f4400118970b</id>
        <published>2010-09-15T07:16:24-05:00</published>
        <updated>2010-10-21T09:36:09-05:00</updated>
        <summary type="html">Exceptional Clinical Benefits for Patients and Physicians Confirmed Data Presented at the European Society of Cardiology Annual Congress ST. LOUIS, Sept. 8 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (NASDAQ: STXS) highlighted significant new additions to the body of evidence demonstrating exceptional clinical outcomes achieved with its Niobe® Magnetic Navigation System in ventricular...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/0YvvKD2rhzk" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/stereotaxis-announces-first-ever-prospective-comparative-clinical-trial-outcome-for-vt-patients-.html</feedburner:origLink></entry>
    <entry>
        <title>Roche Diabetes Care and ICW Announce Technology Partnership </title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/k2qd4OAFZXU/roche-diabetes-care-and-icw-announce-technology-partnership-.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/roche-diabetes-care-and-icw-announce-technology-partnership-.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330134875f0d7a970c</id>
        <published>2010-09-15T07:11:48-05:00</published>
        <updated>2010-10-21T09:35:55-05:00</updated>
        <summary type="html">New Solutions to Ease Interaction Between Healthcare Professionals and Patients MANNHEIM and WALLDORF, Germany, Sept. 8 /PRNewswire/ -- Roche Diabetes Care, a global leader in diabetes care and eHealth specialist InterComponentWare (ICW) today announced a multi-year, global partnership to develop a next-generation web-based solution for efficient diabetes management. The structured...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/k2qd4OAFZXU" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/roche-diabetes-care-and-icw-announce-technology-partnership-.html</feedburner:origLink></entry>
    <entry>
        <title>STAAR Surgical Launches New Visian ICL(TM) Product Line Extensions at ESCRS </title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/uRRJ6RiyMSA/staar-surgical-launches-new-visian-icltm-product-line-extensions-at-escrs-.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/staar-surgical-launches-new-visian-icltm-product-line-extensions-at-escrs-.html" thr:count="1" thr:updated="2010-09-25T02:53:08-05:00" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330133f43ff596970b</id>
        <published>2010-09-15T07:08:20-05:00</published>
        <updated>2010-10-21T09:35:40-05:00</updated>
        <summary type="html">New Visian ICL Allows for Treatment of Virtually All Myopes and Hyperopes New Visian Hyperopic Toric ICL Now Available in International Markets Over 40 Presentations on Visian ICL Successes during Meetings around ESCRS MONROVIA, Calif., Sept. 8 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) , the leading worldwide developer, manufacturer...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/uRRJ6RiyMSA" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/staar-surgical-launches-new-visian-icltm-product-line-extensions-at-escrs-.html</feedburner:origLink></entry>
    <entry>
        <title>GeckoSystems Signs Manufacturing Contract to Expand Elder Care Robot Trials</title>
        <link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/TheClinicalDeviceNewsletter/~3/dSC4oK8lSAU/geckosystems-signs-manufacturing-contract-to-expand-elder-care-robot-trials.html" />
        <link rel="replies" type="text/html" href="http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/geckosystems-signs-manufacturing-contract-to-expand-elder-care-robot-trials.html" thr:count="0" />
        <id>tag:typepad.com,2003:post-6a00e552a56a6188330134875f0345970c</id>
        <published>2010-09-15T07:04:59-05:00</published>
        <updated>2010-10-21T09:35:22-05:00</updated>
        <summary type="html">CONYERS, GA--(Marketwire - September 8, 2010) - GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) announced today that they have signed a contract with Regal Research and Mfg. Co. in Plano, TX, that will further enable the expansion of their ongoing elder care robot trials. GeckoSystems is a dynamic leader in the emerging...&lt;img src="http://feeds.feedburner.com/~r/TheClinicalDeviceNewsletter/~4/dSC4oK8lSAU" height="1" width="1"/&gt;</summary>
        <author>
            <name>Nancy J  Stark</name>
        </author>
        
        



    <feedburner:origLink>http://clinicaldevice.typepad.com/the_clinical_device_newsl/2010/09/geckosystems-signs-manufacturing-contract-to-expand-elder-care-robot-trials.html</feedburner:origLink></entry>
 
</feed><!-- ph=1 -->

